Development of a DNA computing processor for high-precision breast cancer detection via miRNA biomarker analysis

Area of Science:

• Biotechnology
• Computational Biology
• Molecular Diagnostics

Background:

• Early and accurate breast cancer diagnosis is crucial but challenged by complex, costly conventional methods.
• MicroRNA (miRNA) biomarkers show promise for improved diagnostic accuracy.
• Existing diagnostic techniques often lack the required precision and cost-effectiveness for widespread application.

Purpose of the Study:

• To develop a novel DNA computing-based processor for high-precision breast cancer diagnosis using miRNA biomarker analysis.
• To identify critical up-regulated and down-regulated miRNAs associated with breast cancer through comprehensive data analysis.
• To create a scalable, enzyme-free, and cost-effective system for enhanced biomarker-based detection.

Main Methods:

• Analysis of RNA sequencing data from The Cancer Genome Atlas (TCGA) using Differential Expression Gene (DEG) and Weighted Gene Co-expression Network Analysis (WGCNA).
• Integration of identified miRNAs into a DNA computing framework utilizing DNA strand displacement and logic gate design.
• Development of specific components: an increasing detector for oncogenic miRNAs and a decreasing detector for tumor-suppressor miRNAs.

Main Results:

• Identification of critical up-regulated and down-regulated miRNAs for breast cancer detection.
• Simulation results demonstrated robust performance with high positive (0.91) and negative (0.98) predictive values.
• Experimental validation confirmed the functionality of representative miRNAs (miR-200a and miR-141), supporting the system's feasibility.

Conclusions:

• A novel, enzyme-free DNA computing system offers a scalable and cost-effective solution for breast cancer diagnosis.
• The proposed system leverages miRNA biomarkers for high-precision detection, addressing limitations of conventional methods.
• This approach represents a significant advancement in biomarker-based breast cancer detection technology.